Back to Search Start Over

Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional study

Authors :
Ying Yan
Qingyuan Chen
Abudulimutailipu Nuermaimaiti
Yingzi Xiao
Le Chang
Huimin Ji
Huizhen Sun
Qinggang Song
Yuanfeng Gao
Junjie Xu
Lunan Wang
Source :
Human Vaccines & Immunotherapeutics, Vol 19, Iss 3 (2023)
Publication Year :
2023
Publisher :
Taylor & Francis Group, 2023.

Abstract

ABSTRACTHypertension, a prevalent chronic disease, has been associated with increased COVID-19 severity. To promote the COVID-19 booster vaccination of hypertensive patients, this study investigated the willingness to receive boosters and the related influencing factors based on the health belief model (HBM model). Between June and October 2022, 453 valid questionnaires were collected across three Chinese cities. The willingness to receive a booster vaccination was 72.2%. The main factors that influenced the willingness of patients with hypertension to receive a booster shot were male (χ2 = 7.008, p = .008), residence in rural (χ2 = 4.778, p = .029), being in employment (χ2 = 7.232, p = .007), taking no or less antihypertensive medication (χ2 = 9.372, p = .025), with less hypertension-related comorbidities (χ2 = 35.888, p

Details

Language :
English
ISSN :
21645515 and 2164554X
Volume :
19
Issue :
3
Database :
Directory of Open Access Journals
Journal :
Human Vaccines & Immunotherapeutics
Publication Type :
Academic Journal
Accession number :
edsdoj.ff3c5a22c9ba409182f63a2ae963f0f0
Document Type :
article
Full Text :
https://doi.org/10.1080/21645515.2023.2283315